- Home
- / NeoPhore
NeoPhore
Total Funding
$25 M
NeoPhore Summary
Company Summary
- Overview
- NeoPhore is a healthcare company that targets cancer neoantigen research. It manufactures medication promoting neoantigen creation across various cancer types and stimulation of immune system.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Babraham, GB | view all locations
- Website
- https://www.neophore.com/
- Cybersecurity rating
Table of Contents
Key People
Stephen Over, Chief Financial Officer
Julian Blagg, Executive Vice President, Drug Discovery
Philippe Riou, Director of Biology
LocationsView all
2 locations detected
Babraham, England HQ
United Kingdom
Babraham Hall
Altrincham, England
United Kingdom
3rd Floor, 1 Ashley Rd